Centessa Pharmaceuticals plc American Depositary Receipt logo

Centessa Pharmaceuticals plc American Depositary Receipt (CNTA)

Delisted
29 Jun 2026
NASDAQ (NGS) NASDAQ (NGS)
$
40. 50
0
0%
$
6.27B Market Cap
- P/E Ratio
- Div Yield
11.27M Volume
- Eps
$ 40.5
Previous Close
Investors:
Day Range
40.5 40.5
Year Range
12.78 40.56
Want to track CNTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Centessa Pharmaceuticals plc American Depositary Receipt Investors

Name Quantity Cost Value Profit ($) Gain (%)
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
22 $0.66 $0.56 -$0.1 -15.15%
Mathieu Cornu
Mathieu Cornu Pictet Asset Management Holding SA
96,910 $2.67M $2.67M - -
Bayforest Capital Ltd.
Bayforest Capital Ltd. Bayforest Capital Ltd.
1,947 $77,335 $77,335 - -